NPI: 1720623853 · PETERSBURG, VA 23805 · General Acute Care Hospital · NPI assigned 11/13/2019
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 11/13/2019 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 176,265 | $6.74M |
| 2021 | 237,427 | $7.57M |
| 2022 | 255,838 | $9.62M |
| 2023 | 298,255 | $12.54M |
| 2024 | 251,251 | $12.31M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 77,789 | 67,007 | $12.98M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 46,063 | 38,756 | $7.41M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26,971 | 22,566 | $4.41M |
| 96361 | Intravenous infusion, hydration; each additional hour | 10,123 | 8,174 | $2.93M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15,488 | 13,335 | $2.41M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,704 | 9,248 | $1.91M |
| G0378 | Hospital observation service, per hour | 8,676 | 4,839 | $1.26M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6,820 | 5,939 | $1.24M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 19,128 | 4,784 | $934K |
| 93458 | 663 | 571 | $826K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,787 | 4,157 | $805K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,406 | 2,109 | $557K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,892 | 8,028 | $518K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,017 | 883 | $488K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,233 | 1,469 | $433K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,092 | 3,621 | $425K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,462 | 1,297 | $423K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,829 | 6,640 | $403K |
| 36415 | Collection of venous blood by venipuncture | 63,247 | 43,838 | $386K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3,005 | 1,556 | $363K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4,227 | 3,565 | $323K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 6,851 | 4,062 | $318K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,378 | 1,668 | $275K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 479 | 398 | $256K |
| 97161 | 2,490 | 2,190 | $254K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 28,335 | 23,209 | $252K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,417 | 1,328 | $194K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,538 | 3,400 | $178K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 312 | 265 | $178K |
| 76830 | Ultrasound, transvaginal | 1,911 | 1,710 | $175K |
| 80053 | Comprehensive metabolic panel | 49,207 | 38,219 | $165K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,262 | 1,128 | $165K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 735 | 535 | $163K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,003 | 1,777 | $158K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5,797 | 5,409 | $156K |
| 70496 | 772 | 672 | $149K | |
| 93971 | 1,647 | 1,476 | $145K | |
| 71046 | Radiologic examination, chest; 2 views | 9,086 | 8,189 | $131K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,697 | 1,511 | $131K |
| 76642 | 1,254 | 1,035 | $128K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 20,036 | 14,244 | $125K |
| 12001 | 687 | 631 | $120K | |
| 11045 | 294 | 150 | $117K | |
| 93970 | 896 | 802 | $104K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,409 | 1,573 | $100K |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,425 | 3,026 | $99K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,477 | 1,252 | $91K |
| 97162 | 710 | 643 | $80K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 452 | 399 | $77K |
| 80048 | Basic metabolic panel (calcium, ionized) | 16,845 | 12,843 | $73K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 418 | 377 | $70K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 556 | 499 | $68K |
| 36430 | 599 | 432 | $68K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 175 | 164 | $64K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 24,816 | 12,438 | $64K |
| 83880 | 7,075 | 5,788 | $62K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 67 | 63 | $61K |
| 71045 | Radiologic examination, chest; single view | 24,320 | 20,365 | $58K |
| 81001 | 38,149 | 31,774 | $57K | |
| 97014 | 2,211 | 792 | $56K | |
| 71250 | 1,169 | 992 | $54K | |
| 76536 | 507 | 461 | $52K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 34,847 | 27,872 | $51K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 3,345 | 3,219 | $50K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,810 | 1,507 | $50K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7,616 | 6,968 | $47K |
| 72131 | 648 | 576 | $47K | |
| 70486 | 1,220 | 1,092 | $41K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5,326 | 4,775 | $40K |
| 76801 | 1,343 | 1,166 | $40K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,010 | 755 | $40K |
| 70498 | 950 | 837 | $38K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 404 | 381 | $35K |
| 73630 | 2,895 | 2,535 | $34K | |
| 77336 | 258 | 91 | $34K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,957 | 3,615 | $34K |
| 12011 | 203 | 193 | $34K | |
| 10060 | 548 | 497 | $34K | |
| 73562 | 2,811 | 2,367 | $34K | |
| 86901 | 6,328 | 5,430 | $34K | |
| 73610 | 2,734 | 2,442 | $33K | |
| 74018 | 3,322 | 2,876 | $33K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 17,693 | 13,804 | $32K |
| 82962 | 21,315 | 8,326 | $32K | |
| 73030 | 2,861 | 2,469 | $32K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 310 | 212 | $32K |
| 97165 | 882 | 718 | $32K | |
| 76770 | 298 | 266 | $31K | |
| C1769 | Guide wire | 2,364 | 1,764 | $29K |
| 59025 | Fetal non-stress test | 190 | 158 | $28K |
| 73130 | 2,513 | 2,221 | $28K | |
| 85730 | 3,930 | 3,306 | $27K | |
| 74178 | 117 | 101 | $26K | |
| 84484 | 28,439 | 18,054 | $26K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 679 | 610 | $26K |
| 87807 | 2,528 | 2,412 | $25K | |
| 87040 | 4,658 | 2,942 | $25K | |
| 81025 | 15,317 | 13,105 | $25K | |
| 72100 | 1,884 | 1,672 | $25K | |
| 90714 | 1,259 | 1,141 | $24K | |
| 93798 | 171 | 36 | $23K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 9,228 | 7,656 | $23K |
| 71271 | 206 | 197 | $23K | |
| 77066 | Tomosynthesis, mammo | 496 | 453 | $22K |
| 77065 | Tomosynthesis, mammo | 524 | 443 | $22K |
| 0042T | 168 | 145 | $22K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 99 | 92 | $21K |
| 70491 | 85 | 80 | $21K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 60,424 | 45,152 | $20K |
| 87641 | 1,187 | 1,053 | $19K | |
| 73502 | 1,786 | 1,476 | $18K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,611 | 2,946 | $18K |
| 12002 | 116 | 106 | $17K | |
| 90715 | 1,073 | 982 | $17K | |
| 97116 | 784 | 433 | $16K | |
| 73110 | 1,476 | 1,324 | $15K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,738 | 1,447 | $13K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 15 | 14 | $13K |
| 82565 | 1,120 | 938 | $13K | |
| 11043 | 131 | 63 | $12K | |
| 97163 | 177 | 168 | $12K | |
| 92610 | 188 | 156 | $11K | |
| 85027 | 6,944 | 5,583 | $11K | |
| 85379 | 2,688 | 2,347 | $10K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 18 | 12 | $10K |
| 86850 | 5,339 | 4,604 | $9K | |
| 93880 | 90 | 78 | $9K | |
| 84702 | 3,630 | 2,924 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 50 | 41 | $9K |
| 76937 | 393 | 319 | $9K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 19,285 | 14,637 | $9K |
| 73140 | 677 | 632 | $8K | |
| 93308 | 20 | 20 | $8K | |
| 86900 | 6,329 | 5,430 | $8K | |
| 84132 | 2,127 | 1,780 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16,820 | 13,955 | $8K |
| 73564 | 877 | 741 | $8K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 437 | 398 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,775 | 4,505 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,954 | 6,717 | $7K |
| 87077 | 2,741 | 2,194 | $7K | |
| 73080 | 719 | 654 | $7K | |
| 80179 | 1,379 | 1,211 | $6K | |
| 73590 | 907 | 780 | $6K | |
| 80050 | General health panel | 644 | 586 | $6K |
| 76870 | 94 | 84 | $6K | |
| 86923 | 423 | 330 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5,320 | 4,772 | $5K |
| 84145 | 1,421 | 1,079 | $5K | |
| 80143 | 1,374 | 1,207 | $5K | |
| 73552 | 150 | 128 | $5K | |
| 80047 | 889 | 707 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 18,330 | 14,121 | $4K |
| 72141 | 28 | 26 | $4K | |
| 95816 | 20 | 17 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,386 | 2,070 | $4K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 8,739 | 6,780 | $4K |
| 87070 | 6,310 | 5,553 | $4K | |
| 99218 | 171 | 129 | $4K | |
| 96376 | 7,721 | 4,163 | $4K | |
| 71101 | 201 | 182 | $4K | |
| 77290 | 31 | 24 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 8,623 | 6,266 | $4K |
| J2704 | Injection, propofol, 10 mg | 9,209 | 6,635 | $4K |
| 72050 | 272 | 246 | $3K | |
| 72110 | 173 | 162 | $3K | |
| 87210 | 3,115 | 2,695 | $3K | |
| 87088 | 287 | 254 | $3K | |
| 87205 | 1,301 | 951 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,665 | 2,311 | $3K |
| 74174 | 27 | 26 | $3K | |
| 85610 | 6,310 | 5,281 | $3K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 230 | 195 | $3K |
| 97010 | 174 | 62 | $3K | |
| 88307 | 128 | 99 | $3K | |
| 83690 | 12,513 | 10,413 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 567 | 555 | $3K |
| 73090 | 415 | 377 | $2K | |
| 80061 | Lipid panel | 1,155 | 1,000 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,772 | 1,552 | $2K |
| 73560 | 129 | 98 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | 51 | 39 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 3,082 | 2,619 | $2K |
| 82077 | 5,025 | 4,262 | $2K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 82 | 32 | $2K |
| 97166 | 13 | 12 | $2K | |
| 77080 | 28 | 26 | $2K | |
| 81003 | 3,514 | 3,118 | $2K | |
| 83605 | 6,568 | 5,174 | $2K | |
| 84703 | 5,203 | 4,542 | $2K | |
| J2060 | Injection, lorazepam, 2 mg | 1,972 | 1,519 | $2K |
| 87147 | 1,752 | 1,336 | $2K | |
| 83735 | 8,183 | 6,489 | $1K | |
| 86140 | 1,272 | 835 | $1K | |
| 80076 | 1,490 | 1,215 | $1K | |
| 77062 | 208 | 197 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,816 | 5,331 | $1K |
| 80069 | 554 | 370 | $1K | |
| 93325 | 32 | 31 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 8,265 | 5,898 | $1K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 909 | 706 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,272 | 1,805 | $948.37 |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,793 | 2,860 | $893.18 |
| 87808 | 2,186 | 1,971 | $834.57 | |
| 83615 | 107 | 93 | $736.49 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 262 | 218 | $728.12 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4,107 | 3,251 | $710.91 |
| 88341 | 15 | 13 | $708.69 | |
| 73660 | 33 | 25 | $660.67 | |
| 82550 | 2,593 | 2,120 | $635.38 | |
| J2404 | Injection, nicardipine, 0.1 mg | 13 | 12 | $556.30 |
| 87186 | 2,868 | 2,307 | $530.06 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,842 | 11,871 | $527.90 |
| 72040 | 53 | 48 | $519.10 | |
| 87634 | 277 | 272 | $517.27 | |
| 88342 | 239 | 190 | $488.82 | |
| 76000 | 235 | 191 | $479.87 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 1,028 | 744 | $454.51 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,269 | 5,091 | $421.95 |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,787 | 3,337 | $419.65 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 90 | 74 | $412.70 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,365 | 1,143 | $412.27 |
| 94760 | 829 | 534 | $411.56 | |
| 73060 | 45 | 40 | $394.91 | |
| 82272 | 145 | 132 | $372.45 | |
| 82247 | 94 | 64 | $371.30 | |
| 72072 | 48 | 42 | $369.93 | |
| 72170 | 275 | 238 | $360.95 | |
| 77061 | 75 | 63 | $350.78 | |
| 99152 | 1,642 | 1,389 | $321.46 | |
| J7050 | Infusion, normal saline solution, 250 cc | 3,087 | 2,075 | $314.73 |
| 82803 | 1,207 | 922 | $278.19 | |
| J1644 | Injection, heparin sodium, per 1000 units | 4,113 | 1,666 | $259.85 |
| 70360 | 13 | 12 | $257.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 5,525 | 2,136 | $240.94 |
| 73620 | 26 | 25 | $226.69 | |
| 93017 | 32 | 27 | $224.71 | |
| J1940 | Injection, furosemide, up to 20 mg | 1,529 | 853 | $220.19 |
| 84520 | 46 | 39 | $219.49 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 33 | 31 | $192.75 |
| 85652 | 728 | 596 | $190.48 | |
| 88304 | 665 | 522 | $167.38 | |
| 80177 | 125 | 108 | $159.05 | |
| 99153 | Mod sedat endo service >5yrs | 977 | 824 | $150.08 |
| 85018 | 485 | 338 | $148.93 | |
| 84439 | 86 | 74 | $133.50 | |
| 82553 | 114 | 105 | $128.12 | |
| C9113 | Injection, pantoprazole sodium, per vial | 660 | 437 | $122.59 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,171 | 717 | $117.14 |
| J3370 | Injection, vancomycin hcl, 500 mg | 644 | 337 | $105.45 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,706 | 2,074 | $104.45 |
| J1953 | Injection, levetiracetam, 10 mg | 1,194 | 862 | $100.23 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,049 | 844 | $84.15 |
| 82607 | 58 | 49 | $76.80 | |
| 80164 | 19 | 14 | $76.23 | |
| 85014 | 130 | 100 | $65.48 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 589 | 404 | $62.63 |
| 82140 | 90 | 64 | $60.76 | |
| 82570 | 139 | 114 | $60.11 | |
| 94762 | 298 | 261 | $58.41 | |
| 82248 | 572 | 506 | $55.82 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,063 | 806 | $52.59 |
| 82746 | 32 | 25 | $52.20 | |
| 83540 | 81 | 66 | $51.15 | |
| 84550 | 159 | 139 | $51.13 | |
| 82805 | 64 | 51 | $46.64 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,031 | 809 | $42.65 |
| J1630 | Injection, haloperidol, up to 5 mg | 1,106 | 843 | $41.44 |
| 84100 | 434 | 314 | $37.18 | |
| J1815 | Injection, insulin, per 5 units | 326 | 119 | $34.40 |
| J3490 | Unclassified drugs | 7,085 | 3,868 | $26.15 |
| 82150 | 57 | 42 | $23.88 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 616 | 498 | $15.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 606 | 493 | $13.46 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 2,774 | 877 | $12.33 |
| 82728 | 32 | 28 | $12.23 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 15 | 13 | $9.06 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 134 | 103 | $8.74 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 69 | 39 | $7.45 |
| 94761 | 2,808 | 1,756 | $6.39 | |
| 84156 | 29 | 24 | $5.39 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 67 | 52 | $3.38 |
| 82947 | 554 | 460 | $3.16 | |
| J8597 | Antiemetic drug, oral, not otherwise specified | 37 | 28 | $1.65 |
| J1956 | Injection, levofloxacin, 250 mg | 32 | 24 | $1.61 |
| J8540 | Dexamethasone, oral, 0.25 mg | 271 | 242 | $1.28 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 32 | 26 | $0.80 |
| J3360 | Injection, diazepam, up to 5 mg | 16 | 14 | $0.54 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 602 | 545 | $0.00 |
| 84295 | 520 | 441 | $0.00 | |
| 29125 | 84 | 81 | $0.00 | |
| 96367 | 126 | 104 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 69 | 65 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 91 | 80 | $0.00 |
| T5999 | Supply, not otherwise specified | 77 | 75 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 262 | 238 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 449 | 344 | $0.00 |
| 87150 | 14 | 13 | $0.00 | |
| 93356 | 52 | 46 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 138 | 68 | $0.00 |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 18 | 12 | $0.00 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 27 | 25 | $0.00 |
| 88312 | 27 | 24 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 391 | 308 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 111 | 87 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 38 | 26 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 84 | 64 | $0.00 |
| 82330 | 567 | 477 | $0.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 13 | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,274 | 1,180 | $0.00 |
| 77417 | 30 | 12 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 66 | 64 | $0.00 |
| 86592 | 30 | 27 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 26 | 13 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 69 | 56 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 13 | 12 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 23 | 19 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 166 | 120 | $0.00 |
| 96368 | 14 | 12 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 73 | 71 | $0.00 |
| A9609 | Fludeoxyglucose f18 up to 15 millicuries | 13 | 12 | $0.00 |
| 87340 | 16 | 13 | $0.00 |